PMID: 350263May 1, 1978

Topical atenolol versus pilocarpine: a double-blind study of the effect on ocular tension

The British Journal of Ophthalmology
K WettrellM Pandolfi

Abstract

Topical atenolol (a beta1-adrenoceptive antagonist), pilocarpine, and placebo were tested in a randomised double-blind crossover trial of 8 patients with ocular hypertenion. Atenolol (2% 3 times a day) caused a fall in intraocular pressure (IOP) comparable to that achieved by topical application of pilocarpine (2% 3 times a day). The decrease in IOP by each compound was demonstrable on the second day of application and was significantly (P is less than 0.05) reduced on the seventh and 14th days of treatment. The combination of 2% pilocarpine and 2% atenolol administered 15 minutes apart (3 times a day) lowered the IOP significantly from the second day of treatment, and this reduction persisted throughout the trial period of 14 days. This combined of treatment, treatment lowered the IOP more than either substance alone. However, this further decrease was statistically significant only on the 14th day of treatment (atenolol versus atenolol + pilocarpine, P is less than 0.05). No change of the episcleral venous pressure was observed after 14 days' treatment with either atenolol or pilocarpine alone, or combined.

References

Nov 1, 1976·The British Journal of Ophthalmology·M J MacdonaldC I Phillips
Dec 11, 1976·British Medical Journal·C I PhillipsP M Cullen
Jun 1, 1975·The British Journal of Ophthalmology·M J ElliotC I Phillips
Apr 22, 1977·Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology·G K KrieglsteinW Leydhecker
Apr 1, 1977·Archives of Ophthalmology·T J Zimmerman, H E Kaufman
May 1, 1977·The British Journal of Ophthalmology·K Wettrell, M Pandolfi
May 1, 1977·The British Journal of Ophthalmology·M J MacdonaldC I Phillips
May 1, 1977·The British Journal of Ophthalmology·C I PhillipsP M Cullen
Jun 1, 1975·The British Journal of Ophthalmology·I Bonomi, P Steindler
Mar 1, 1973·The British Journal of Ophthalmology·J Vale, C I Phillips
Oct 1, 1972·The British Journal of Ophthalmology·J ValeC I Phillips

Citations

Jan 1, 1985·Journal of Ocular Pharmacology·M A McLaughlin, G C Chiou
Dec 17, 1998·Ophthalmology·M M AbreuP A Netland
Apr 4, 2014·Biological & Pharmaceutical Bulletin·Irhan Ibrahim Abu HashimHidetoshi Arima
Dec 1, 1979·The British Journal of Ophthalmology·P J AiraksinenE A Jaanio
Jul 2, 1979·Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology·M Ober, A Scharrer

Related Concepts

Tenormin
Clinical Trials
Double-Blind Method
Polychemotherapy
Physiologic Intraocular Pressure
Ophthalmic Solution
Salagen
Propanolamines

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Computational Methods for Protein Structures

Computational methods employing machine learning algorithms are powerful tools that can be used to predict the effect of mutations on protein structure. This is important in neurodegenerative disorders, where some mutations can cause the formation of toxic protein aggregations. This feed follows the latests insights into the relationships between mutation and protein structure leading to better understanding of disease.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

© 2021 Meta ULC. All rights reserved